Purchase Order 75F40121P00501
Award Date 9/2/21
Potential Completion Date 12/1/23
Potential Value $429K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
Total Small Business
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Austin, TX 78759, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Service Contract Inventory
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed price purchase order contract awarded by the Department of Health and Human Services Food and Drug Administration (FDA) to Toxstrategies, LLC, a small business based in Austin, Texas. The contract is for a "TALC REVIEW" with a potential value of $193,500.00 and a completion date of April 1, 2021. The contract was awarded on a total small business set-aside basis in response to a solicitation posted on August 28, 2019, with proposals due by September 6, 2019....
- This is a $409,585.51 firm fixed-price purchase order awarded by the Food and Drug Administration (FDA) to the Society of Toxicology (SOT), a non-profit organization, in Fiscal Year 2024. The purpose of this contract is for SOT to provide no more than four one-half day workshops on toxicological science challenges related to food and ingredient safety. This contract does not have a set-aside designation. The FDA has previously awarded similar fixed-price contracts and grants to SOT to support...
- This is a firm fixed price purchase order awarded by the Department of Health and Human Services Food and Drug Administration (FDA) to The Society of Toxicology (SOT), a non-profit organization, for $167,066.04. The contract is for the provision of toxicology training workshops and colloquia on emerging issues in food and ingredient safety, as outlined in a previous Memorandum of Understanding between the FDA and SOT. The training is intended to educate FDA regulatory and public health...
- This is a $9,388,620.00 firm fixed price definitive contract awarded by the Food and Drug Administration (FDA) to Strategi Consulting, LLC, a small disadvantaged, woman-owned business. The objective is to provide continuous data reconciliation, ad-hoc reporting, and analytics capabilities to support the FDA's ethics program. The contract does not have a set-aside designation and has an ultimate completion date of May 23, 2030. Strategi Consulting holds several significant federal contract...
- This is a $597,340.00 Firm Fixed Price contract awarded by the Food and Drug Administration (FDA) to QPS LLC, a minority-owned limited liability company, for a scientific study related to the assessment of in vitro percutaneous absorption, in vitro rate of release, and physicochemical properties. The contract does not have a set-aside designation, indicating it was an open market procurement. QPS LLC is an experienced federal contractor, having been awarded multiple contracts and task orders...
- This is a firm fixed price purchase order contract awarded by the Food and Drug Administration (FDA) to Integrated Laboratory Systems, LLC (ILS), a small business contractor, in the amount of $167,767.00. The contract is for a "Fragrance Study Titled, 'Evaluation of the Allergenicity and Sensitization Potential of Fragrance Substances Based on Survey of Scientific Literature.'" As a small business set-aside contract, ILS will conduct this research study on the allergenicity and...
- The Food and Drug Administration awarded a $453,154 delivery order to Vets Synergetic Group LLC, a minority-owned, SBA-certified 8(a) Joint Venture small business based in Leesburg, Virginia, for the development and standardization of predictive toxicology platforms aimed at identifying potential chemical hazards in foods and food-related products. The firm fixed price delivery order is scheduled for completion by September 6, 2026, and represents work performed under the company's larger FDA...
- Toxicologic Pathology Associates Inc. was awarded a $20.7 million definitive contract by the Department of Health and Human Services' Food and Drug Administration to provide onsite pathology services from July 2015 through July 2020. The contract has a small business set aside designation. As part of its mission to protect public health, the FDA utilizes pathology expertise to evaluate samples for issues impacting medical products and the safety of the food supply. This award draws on the...
- This is a delivery order contract awarded by the Department of Health and Human Services (HHS) Food and Drug Administration (FDA) to Ihrc, Incorporated, a self-certified small disadvantaged, woman-owned business. The contract is for a Subject Matter Expert to support the development and evaluation of microbiological methods for cosmetics. It is a firm fixed price contract with a potential value of $798,872.66 and a completion date of August 16, 2023. The contract was issued under the FDA's...
- This is a $140,000.00 firm-fixed-price purchase order awarded by the Food and Drug Administration (FDA) to Altamira, LLC, a minority-owned and woman-owned small business. The contract provides a software license and maintenance support for the Chem Tunes ToxGPS platform, which assists with chemical data management, virtual liver modeling, and toxicity prediction to support the FDA's environmental protection and drug development mission. Altamira, a prime contractor without major...